Member Info for Parpaing

has signed a new drilling contract with Tullow Namibia Ltd., for a one-well drilling program plus options for drilling offshore West Africa. The contract is expected to commence in the third quarter of 2018. https://globenewswire.com/news-release/2018/02/26/1387375/0/en/Ocean-Rig-UDW-Inc-Announces-New-Drilling-Contract-for-the-Ocean-Rig-Poseidon.html

https://www.vegware.com/ https://www.itv.com/news/2018-02-15/plastic-can-you-live-without-it-tonight/

A company called vegware in ITV last night stated "By making products that are made of compostable materials it means that that whole cup and any frothy milk or any food that's left in our packaging can all go into one bin and they will be taken for commercial composting...which can be put back in agricultural life." So who's Vegware that sells the coffee cup? Is it related to BIOME?

Probably because Peel Hunt is the NOMAD and corporate broker to TRP. TRP maybe can't pay their bills to Peel Hunt and Peel Hunt is getting 'paid' in shares.

What company is SYP? I can't find it.

You are right Goldust. I can see the SP at 20 GBP in a few months as there are only 2.35 million share available.

BIOM is getting popular and this will be a very busy year for the management and team. Good luck all.

Up 44% in the bioplastics division. It's starting to bode well for BIOM. Well done Biome for the continuous hard work. Pity the government is only interested in taxation instead of banning oil-based plastics in food packaging forever.

About thru drill in the 2nd half of 2018.

has bounced back to 2.23

well, read this then ... http://www.businesswire.com/news/home/20171115005234/en/Xenetic-Biosciences-Reports-2017-Quarter-Financial-Results

Check out the website for the AGM info. With the 7 million gained in November the company con continue to Q2 2018. The SP took a dive after the AGM and financial results.

Not the most interesting quarterly report published.

From BIOM. Well done team !

and Scott is leaving the company.

Hola ! Buenos dias from a HOT country - Spain.☺ I'm not confident at all on the clinical trials, because there is not much information available. the latest trial info is October 2017. If you go to XEN website (https://www.xeneticbio.com/product-pipeline/xbio-101) you will see a clinical trials link that doesn't work. However, you can go to https://www.clinicaltrials.gov/ct2/show/NCT02064725?term=NCT02064725&rank=1 which shows an ongoing clinical trial managed by Kevelt AS. The XEN website refers to its XBIO 101 drug which is not mentioned in the clinical trial. The clinical trial mentions 'Virexxa'. and no news since Jan 2017. If you look for sodium cridanimod on the clinical trials site, you will see XEN responsible for a trial at: https://www.clinicaltrials.gov/ct2/show/NCT03077698?term=Sodium+Cridanimod&rank=2 This study will finish on Nov 30, 2020. There are several hospitals that are recruiting and some not recruiting yet. The 'other' name for sodium cridanimod is Megestrol Acetate. There are 74 studies listed about this drug. Scotty hasn't been forthcoming with any news and I am not sure that XEN can survive until 2020 for the results of its drug in the trial. The XEN or XBIO website has not been updated and Scotty appears to be burying his head in the sand or am I wrong?

I hope. I have a hunch that the trial results for ErepoXen are almost out. The previous trials showed that Erepoxen maintained EPO protein levels about 400 hours compared to only 22 hours or standard recombinant EPO protein. This quite significant for chronic kidney disease patients. Check out www.seruminstitute.com/product_horizon.php. Talking about commercialization?

But scarce news. Maybe we have got a nice surprise coming.

on the company's twitter, LinkedIn, faceboo or Google+ pages since June 26. That worries me.

of Stockholders. the meeting has been delayed again, and will be rescheduled late this year. Is this because they have good news or is it because they have very bad news? Apparently, we have to vote on the updated 'proposals'. Any ideas?